Beta Bionics, Inc.
NASDAQBeta Bionics heads into its May 21 earnings report with one of the most striking disconnects in its recent history: analysts are nearly unanimous in their bullish ratings, yet have spent months slashing the price targets that back those calls. The analyst picture tells the clearest story heading into the print. Goldman Sachs, Stifel, Truist, and Leerink Partners all hold Buy or…
Snapshot as of 20 May 2026
Beta Bionics heads into its May 21 earnings report with one of the most striking disconnects in its recent history: analysts are nearly unanimous in their bullish ratings, yet have spent months slashing the price…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BBNX — free to start on ORTEX.
Sign up for free →Open BBNX on ORTEX